NewsEvents

Your Yourlocation: Home > Clinical observation of domestic tiotropium bromide(136310-93-5) combined with salmeterol in the treatment of stable COPD

To observe the clinical efficacy of domestic tiotropium bromide(136310-93-5) combined with salmeterol in the stable phase of chronic obstructive pulmonary disease (COPD). Methods: Forty - seven patients with COPD were randomly divided into observation group and control group. The observation group was treated with tiotropium bromide and salmeterol inhalation for 3 months. The control group was treated with salmeterol inoculation and treated for 3 months. FEV1, FEV1 /FVC and FEV1% were used to evaluate the changes of lung function before and after treatment, and the clinical symptoms and signs were evaluated before and after treatment. Results: The scores of lung function and clinical symptoms were significantly better in the observation group than in the control group (P <0.05). Conclusion: The combination of domestic long-acting anticholinergic tiotropium bromide(136310-93-5) and salmeterol in the treatment of COPD can significantly improve the pulmonary function and clinical symptoms of COPD patients, better than the simple application of salmeterol texasone, COPD can be well controlled.

Address:211#Zhengfeng Building,Huanbaokejiyuan, Gaoxinkaifaqu, Jinan,250100,China TEL:086-531-82375818 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved